SBM-05

N/A

Report date: 2026/02/11 20:01:36

Base Information

Drug NameSBM-05
Drug Alias NameSBM-05SBM05
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Biosimilar
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUrologic NeoplasmsEndometrial NeoplasmsCarcinoma, Non-Small-Cell Lung +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShilpa Biologicals Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShilpa Biologicals Pvt Ltd
Inactive CompaniesN/A
Active IndicationsUrologic NeoplasmsEndometrial NeoplasmsCarcinoma, Non-Small-Cell Lung +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A